Thérapie génique des hémophilies — Potentialités thérapeutiques et limitations technologiques
- 1 January 1997
- journal article
- abstracts
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 4 (3) , 251-261
- https://doi.org/10.1016/s1246-7820(97)80049-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Human Clotting Factor VIII cDNA Contains an Autonomously Replicating Sequence Consensus- and Matrix Attachment Region-Like Sequence That Binds a Nuclear Factor, Represses Heterologous Gene Expression, and Mediates the Transcriptional Effects of Sodium ButyrateMolecular and Cellular Biology, 1996
- Gene therapy using retroviral vectorsCurrent Opinion in Biotechnology, 1994
- Gene therapy using adenoviral vectorsCurrent Opinion in Biotechnology, 1994
- Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicityCurrent Opinion in Oncology, 1994
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosisPublished by Elsevier ,1993
- Towards gene therapy for haemophilia B using primary human keratinocytesNature Genetics, 1993
- Human gene therapyScience, 1992
- Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia BBlood, 1989
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977